Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Mar;25(1):3-9.
doi: 10.1007/s00345-007-0145-z. Epub 2007 Feb 14.

Overdiagnosis and overtreatment of early detected prostate cancer

C H Bangma  1 , S Roemeling, F H Schröder
Affiliations
Review

Overdiagnosis and overtreatment of early detected prostate cancer

C H Bangma et al. World J Urol. 2007 Mar.

Abstract

Early detection of prostate cancer is associated with the diagnosis of a considerable proportion of cancers that are indolent, and that will hardly ever become symptomatic during lifetime. Such overdiagnosis should be avoided in all forms of screening because of potential adverse psychological and somatic side effects. The main threat of overdiagnosis is overtreatment of indolent disease. Men with prostate cancer that is likely to be indolent may be offered active surveillance. Evaluation of active surveillance studies and validation of new biological parameters for risk assessment are expected.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/ijc.1588', 'is_inner': False, 'url': 'https://doi.org/10.1002/ijc.1588'}, {'type': 'PubMed', 'value': '11774270', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11774270/'}]}
    2. de Koning HJ, Auvinen A, Berenguer Sanchez A et al (2002) Large-scale randomized prostate cancer screening trials: program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial. Int J Cancer 97(2):237–244 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1093/heapro/dah405', 'is_inner': False, 'url': 'https://doi.org/10.1093/heapro/dah405'}, {'type': 'PubMed', 'value': '15520039', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15520039/'}]}
    2. Lowe JB, Ball J, Lynch BM et al (2004) Acceptability and feasibility of a community-based screening programme for melanoma in Australia. Health Promot Int 19(4):437–444 - PubMed
    1. Van Iersel CA, de Koning HJ, Draisma G et al (2006) Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer (in press) - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa060476', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa060476'}, {'type': 'PubMed', 'value': '17065637', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17065637/'}]}
    2. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS (2006). Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355(17):1763–1771 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0197-2456(00)00099-4', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0197-2456(00)00099-4'}, {'type': 'PubMed', 'value': '11189685', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11189685/'}]}
    2. O’Brien B, Nichaman L, Browne JE, Levin DL, Prorok PC, Gohagan JK (2000) Prostate, lung, colorectal and ovarian cancer screening trial project team. coordination and management of a large multicenter screening trial: the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21(Suppl 6):310S–328S - PubMed

Publication types